Innovation

Cell & Gene Therapy

Taranis Capital and EEC Partner to Build Next-Generation Data Centres

Taranis Capital and Emaar Executive Company partner to develop carrier-neutral data centres across Saudi Arabia, supporting rising AI and cloud demand under Vision 2030

Taranis Capital Limited (“Taranis”), a DFSA-regulated investment firm based in Dubai International Financial Centre (DIFC), has signed a Memorandum of Understanding (MOU) with Emaar Executive Company (EEC) to develop, construct, and operate a portfolio of next-generation, carr

Mark Walker  · 
AgriTech

UAE's agritech push: food security as industrial policy

The Emirates Food Security Council has expanded its mandate to cover controlled-environment agriculture, cell-cultured protein, and desalination-linked aquaculture — with state capital behind each.

The UAE imports roughly 85 per cent of its food. For a country that has made state-capacity industrial policy a signature of its modernisation, that number is not a fact to be accepted — it is a problem to be solved with capital and technology.

The Biotech Times Editorial Team  · 
Medical Devices

IBA to install first gantry proton therapy centre in central Italy

IBA has signed a contract with Rome's IFO to deliver a Proteus ONE proton therapy system, bringing gantry-based treatment to central and southern
IBA has signed a contract with Rome's IFO to deliver a Proteus ONE proton therapy system, bringing gantry-based treatment to central and southern
The Biotech Times Editorial Team  · 
AgriTech
Synthetic Biology

Cibus and Crystal Crop partner to gene-edit India's mustard crop

The deal gives Crystal Crop exclusive India rights to Cibus gene-editing technology targeting higher mustard yields across 8.5 million hectares.
The deal gives Crystal Crop exclusive India rights to Cibus gene-editing technology targeting higher mustard yields across 8.5 million hectares.
The Biotech Times Editorial Team  · 
Digital Health

Ingenio Care launches AI-enabled national healthcare marketplace

The Illinois-based digital health company says its marketplace lists over 7.5 million US providers with CMS pricing and quality data.
The Illinois-based digital health company says its marketplace lists over 7.5 million US providers with CMS pricing and quality data.
The Biotech Times Editorial Team  · 
Medical Devices
Diagnostics
Pharmaceuticals
Cell & Gene Therapy
Biologics

Penn Medicine and IBA form Noventra Oncology Alliance JV

The joint venture will offer end-to-end advisory and operational support to health systems building or expanding proton therapy programmes worldwide.
The joint venture will offer end-to-end advisory and operational support to health systems building or expanding proton therapy programmes worldwide.
The Biotech Times Editorial Team  · 
Cell & Gene Therapy
Biologics
Bioprocessing

Avaí Bio and Austrianova present Klothonova encapsulated-cell data

The preclinical joint venture presented its α-Klotho cell-encapsulation programme at a Miami longevity conference, outlining progress on a GMP cell bank.
The preclinical joint venture presented its α-Klotho cell-encapsulation programme at a Miami longevity conference, outlining progress on a GMP cell bank.
The Biotech Times Editorial Team  · 
Pharmaceuticals
Biologics

Actimed Therapeutics completes PROACT Phase 2a recruitment

The London biotech has enrolled over 100 patients in a trial testing S-pindolol benzoate to preserve lean mass during and after semaglutide therapy.
The London biotech has enrolled over 100 patients in a trial testing S-pindolol benzoate to preserve lean mass during and after semaglutide therapy.
The Biotech Times Editorial Team  · 
Diagnostics
Digital Health

PhAST Corp. wins FDA clearance for rapid blood culture AST panel

PhAST Corp.'s Gram-negative panel delivers antimicrobial susceptibility results in under 2.5 hours directly from positive blood cultures, cutting a typical 24-48
PhAST Corp.'s Gram-negative panel delivers antimicrobial susceptibility results in under 2.5 hours directly from positive blood cultures, cutting a typical 24-48
The Biotech Times Editorial Team  · 
Diagnostics
Medical Devices
Digital Health

Adaptyx wins FDA Breakthrough Device tag for cortisol monitor

Adaptyx Biosciences has secured FDA Breakthrough Device Designation and TAP entry for its continuous cortisol wearable, targeting Cushing syndrome and adrenal
Adaptyx Biosciences has secured FDA Breakthrough Device Designation and TAP entry for its continuous cortisol wearable, targeting Cushing syndrome and adrenal
The Biotech Times Editorial Team  · 
Medical Devices

Traferox X°Port Heart wins FDA 510(k) clearance for transplant use

Traferox Technologies has secured FDA 510(k) clearance for its X°Port Heart Preservation System, targeting improved donor heart outcomes via 10°C static cold
Traferox Technologies has secured FDA 510(k) clearance for its X°Port Heart Preservation System, targeting improved donor heart outcomes via 10°C static cold
The Biotech Times Editorial Team  · 
Medical Devices
Biologics

Dialybrid raises €15m Series A and achieves first-in-human implant

The Italian medtech closed a €15m Series A and implanted its Silkothane® hybrid arteriovenous graft in its first patient in an ongoing Italian pilot trial.
The Italian medtech closed a €15m Series A and implanted its Silkothane® hybrid arteriovenous graft in its first patient in an ongoing Italian pilot trial.
The Biotech Times Editorial Team  · 
Biotech

Patient safety checklist marks 25 years with reform agenda unfinished

Dr Peter Pronovost's ICU infection checklist turns 25, but patient harm rates in US hospitals have barely shifted in a generation.
Dr Peter Pronovost's ICU infection checklist turns 25, but patient harm rates in US hospitals have barely shifted in a generation.
The Biotech Times Editorial Team  · 
Medical Devices
Diagnostics

Fakih IVF marks UAE 15th anniversary with free IVF initiative

The Dubai fertility group will provide 15 complimentary IVF cycles to families facing financial barriers, timed to the UAE's Year of the Family.
The Dubai fertility group will provide 15 complimentary IVF cycles to families facing financial barriers, timed to the UAE's Year of the Family.
The Biotech Times Editorial Team  · 
Digital Health

New Era Energy inks 20-year, 207 MW power deal with Vistra

New Era Energy & Digital has contracted firm power for Phase 1 of its Texas data centre, with Vistra supplying up to 207 MW from an
New Era Energy & Digital has contracted firm power for Phase 1 of its Texas data centre, with Vistra supplying up to 207 MW from an
The Biotech Times Editorial Team  · 
Medical Devices

Z Optics presents six-month IOL data at ESCRS 2026

Z Optics reported zero halos and strong visual acuity across lighting conditions for its Z+ Virtual Aperture IOL in a 43-patient single-centre study.
Z Optics reported zero halos and strong visual acuity across lighting conditions for its Z+ Virtual Aperture IOL in a 43-patient single-centre study.
The Biotech Times Editorial Team  · 
Medical Devices

Milestone Scientific adds Pain and Spine to CompuFlo Programme

Milestone Scientific named Pain and Spine Specialists and Dr Sudhir Rao as development partners to advance its CompuFlo epidural confirmation technology.
Milestone Scientific named Pain and Spine Specialists and Dr Sudhir Rao as development partners to advance its CompuFlo epidural confirmation technology.
The Biotech Times Editorial Team  · 
Medical Devices

AVAVA raises $45m to scale Focal Point Technology aesthetics platform

AVAVA secured a $45m mixed equity and debt round led by returning backer Catalio Capital to fund commercial expansion and its next-generation device pipeline.
AVAVA secured a $45m mixed equity and debt round led by returning backer Catalio Capital to fund commercial expansion and its next-generation device pipeline.
The Biotech Times Editorial Team  · 
Medical Devices
Diagnostics

CooperCompanies posts $1.07bn Q3 revenue amid CVI inventory drag

CooperCompanies hit $1.07bn in Q3 revenue but warned a US channel inventory reduction at CooperVision will weigh into the fourth quarter.
CooperCompanies hit $1.07bn in Q3 revenue but warned a US channel inventory reduction at CooperVision will weigh into the fourth quarter.
The Biotech Times Editorial Team  · 
Digital Health
Diagnostics

Ultrahuman merges ring data with medical records via HealthEx

Ultrahuman's HealthEx PowerPlug links continuous wearable biomarkers to a member's full medical history, aiming to close gaps in fragmented US healthcare records.
Ultrahuman's HealthEx PowerPlug links continuous wearable biomarkers to a member's full medical history, aiming to close gaps in fragmented US healthcare records.
The Biotech Times Editorial Team  · 
Subscribe to Innovation